In this study, we demonstrate that constitutive activation of Raf-1
oncogenic signaling induces stabilization and accumulation of Aurora-A mitotic
kinase that ultimately drives the transition from an epithelial to a highly
invasive mesenchymal phenotype in estrogen receptor α-positive
(ERα+) breast cancer cells. The transition from an
epithelial- to a mesenchymal-like phenotype was characterized by reduced
expression of ERα, HER-2/Neu overexpression and loss of CD24 surface
receptor (CD24 –/low). Importantly, expression of key
epithelial-to-mesenchymal transition (EMT) markers and upregulation of the
stemness gene SOX2 was linked to acquisition of stem cell-like
properties such as the ability to form mammospheres in vitro
and tumor self-renewal in vivo. Moreover, aberrant Aurora-A
kinase activity induced phosphorylation and nuclear translocation of SMAD5,
indicating a novel interplay between Aurora-A and SMAD5 signaling pathways in
the development of EMT, stemness and ultimately tumor progression. Importantly,
pharmacological and molecular inhibition of Aurora-A kinase activity restored a
CD24+ epithelial phenotype that was coupled to ERα
expression, downregulation of HER-2/Neu, inhibition of EMT and impaired
self-renewal ability, resulting in the suppression of distant metastases. Taken
together, our findings show for the first time the causal role of Aurora-A
kinase in the activation of EMT pathway responsible for the development of
distant metastases in ERα+ breast cancer cells. Moreover, this
study has important translational implications because it highlights the mitotic
kinase Aurora-A as a novel promising therapeutic target to selectively eliminate
highly invasive cancer cells and improve the disease-free and overall survival
of ERα+ breast cancer patients resistant to conventional
endocrine therapy.
Objective. Defective circulating dendritic cells (DCs) have been described in systemic lupus erythematosus (SLE) and correlated with high levels of interferon-␣ (IFN␣). DCs are differentiated as being either myeloid or plasmacytoid, according to chemokine expression and the tendency to migrate toward inflamed tissue. We investigated the potential role of interleukin-18 (IL-18) in driving the glomerular migration of DCs in lupus nephritis (LN) and in affecting the ability of DCs to induce an imbalance in the Th1:Th2 ratio.Methods. DC subsets were characterized by flow cytometry and defined as either myeloid or plasmacytoid according to the expression of CD11c/blood dendritic cell antigen 1 (BDCA-1) and CD123/BDCA-2, respectively. The serum Th1:
Lupus nephritis (LN) occurs in more that one-third of patients with systemic lupus erythematosus. Production of nephritogenic autoantibodies, glomerular immune complex deposition, and cytokine overproduction have been postulated to contribute to the pathogenesis of LN. However, overexpression of chemokines and imbalance of dendritic cell (DC) homeostasis may contribute to the development of nephritis in SLE. We present evidence that monocyte chemoattractant protein (MCP)-1 promotes renal disease in experimental glomerulonephritis, while its increased urinary levels reflect the severity of the disease in humans. Although macrophages are the prevalent infiltrating population within the kidney, it has been recently proposed that several chemokines and related receptors expressed by DCs may divide this cell population into myeloid (mDC) and plasmacytoid (pDC) subsets. However, the chemokine receptors expressed by pDCs are not functional, and other molecules are involved in the chemoattraction of these cells. We found increased expression of interleukin (IL)-18 in glomeruli of patients with active LN along with glomerular infiltration by pDCS. Since pDCs bear IL-18 receptor (IL-18R), it is conceivable that circulating pDCs may migrate toward glomeruli by IL-18/IL-18R interactions. Therefore, the relative depletion of circulating pDCs reflects the severity of inflammatory disease in LN.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.